Niki Erlenmeyer-KimlingMyrna M. WeissmanJeremy Veenstra-VanderWeeleRisë B. GoldsteinMark D UnderwoodGergely F TuriWilliam P FiferMarilyn CyrCheryl CorcoranDavid PagliaccioEvan GilmerLisa HolperJiook ChaDavid AbrahamsenKelly E GillRodolfo J Ricart ArbonaJustine MassonJared X Van SnellenbergAndrea PaykinDolores MalaspinaSeth G DisnerReilly KayserKate O'MalleyLupo Geronazzo-AlmanAndrew E. SkodolClaudia RaffulMichael D MasucciAngela E Lee-WinnEduardo LeonardoKinga Edit FodorLung-Chang ChienAimee N C CampbellAnna E SilbermanJose M RubioAna OrtinRebecca GiguereRachel FremontMartin C McElhineyJoanna E SteinglassKally C O'Reilly
P108
Treatment of Psychosis and Agitation in Alzheimer's DiseaseCommunity I-STAR Mozambique: Community Implementation of SBIRT Using Technology for Alcohol Use Reduction in MozambiqueTraining Providers to Conduct PRIDES-sSAComparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With DepressionPre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant TreatmentParent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity DisorderParoxetine/Bupropion in Suicide Attempters/Ideators With Major DepressionProzac Treatment of Major Depression: Discontinuation StudyOpen-label Ziprasidone Study for Psychosis Treatment in AdolescentsA Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine DependenceGabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance PatientsOpen Trial of Family-Based Treatment for Anorexia NervosaAntipsychotic Discontinuation in Alzheimer's DiseaseEffect of Baclofen on Marijuana Withdrawal and RelapseComparison Between Marijuana Smoked in Cigarette Paper Versus Cigar PaperEffects of Aripiprazole on Cocaine Craving and Self-AdministrationEffects of Vigabatrin on Cocaine Self-AdministrationEffect of Lofexidine and Oral THC on Marijuana Withdrawal and RelapseEffects of Smoked Marijuana on Risk Taking and Decision Making TasksSTAR*D Alcohol: Treatment of Depression Concurrent With Alcohol AbuseEnhancing Attention in Adults With Compulsive HoardingPilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)Training Clinicians in Motivational InterviewingImaging the Neurobiology of Behavioral and Medication Treatment for Cocaine DependenceOpen-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis DependenceA Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal BehaviorVilazodone for Separation Anxiety DisorderAntidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older AdultsPrescription Opioid Abuse Among Pain Patients: Predictors of RelapseUnderstanding and Intervening With Heavy Drinking Among Patients With HIV and HCVInfluence of Tobacco Use on Cannabis UseThe Police-Mental Health Linkage SystemD-serine Augmentation of NeuroplasticityBuprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent IndividualsEffects of Cannabis on Prescription Drug Abuse Liability and AnalgesiaTranscranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1Treatment Outcome in CBT for Cocaine UseFeasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCDA Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders
P859
Q16201407-713feab4-4b77-5fbb-e023-4385517916cbQ37392598-240E7C0A-C5FF-4F7D-8596-6F4C3E1814B3Q40283949-5608DA6D-4AF4-4534-897A-7BFC354CBE0FQ40822917-2116968B-8EDE-450F-81BB-243614069618Q46727274-5A1F0C4A-BF39-46C6-8F97-EFB9D0007DC4Q46953542-CD9B904C-CD5E-49DC-8162-6A30AE2E4FFAQ47164237-4721983E-0767-4631-AF8C-6C7CD0C6E7EAQ47699161-B4CF45AA-D149-4185-AE69-CBDF609BC24AQ47703366-AA142C69-DE48-40AA-AF97-75A826899A9AQ47817691-5E85E9A7-896E-44A1-A2F1-D0171E7AC22EQ47818266-C801F997-ED76-4DEF-99EB-4BF63E532B99Q47955840-1EAD8127-D7D5-402F-AF55-4418528CB586Q48302644-B3D051A2-57D7-42CB-AEB0-EBAE0F987845Q5230583-c8ef7c7b-4999-6de7-06da-dc800a3f40adQ57002487-4758DCE0-A900-47FA-99D4-FC5973075FEFQ57543602-534628CB-C70F-427A-ACA1-5E15C91089B8Q58203482-CAFC1002-1375-4031-9B5B-C81D62E17948Q58218646-BFEFA47D-EC56-4F64-947A-5DDAC6872A98Q60056727-C078770F-D965-4552-9DE7-3978F2C1EB76Q60154194-C3922BCB-56F8-4E35-814D-6A5044527E64Q60169674-F8FD67C8-651D-495D-9FCE-3B6D18DFAAF7Q60172219-F2E3EFAD-20D0-4C84-AA56-606A64483A86Q60447311-30F4ACB7-A75B-4BF5-9B2A-566518C57954Q60649269-FC12E44B-45D9-49A6-9C1D-CF986703E55EQ60679692-54512afe-4fe1-a19b-4fab-c667c9906607Q60920568-5EF1F4DE-4AF1-4CD9-B7A2-33D461835FB8Q61157722-29D9C011-9B56-4947-9F0A-F62C6DF90963Q61313246-E4836349-2C1E-420D-90A6-C679AB48FF39Q71663560-6EC88C53-669B-42A2-B147-96046B8BED61Q85871717-BBD7C6FA-1883-4090-8A1B-FEB812D87EE7Q85871717-D07FA950-9467-432F-891F-AD05875D47B1Q86184940-77A796E3-D231-4607-AB14-484EF4660DC8Q87177142-0088471A-A460-442C-B9FC-7F157973B4D5Q87354526-C26A5D7B-D22C-40EC-96A2-9009827883F0Q87796423-F77373F4-AC21-4E25-BD79-087EBF657C21Q87858295-697C10DB-629F-4A05-8413-1BFC5BF5E22DQ87858295-8AC90275-0A07-412B-A6C2-B812BEF00575Q88284107-56783E08-ECE6-4B5B-ACA7-39D2BCF9607DQ89278254-64B6C220-2315-4A9B-8286-DFFC3F355AB1Q89510267-223E9127-3297-4CB1-B4D1-A65B8C7314AB
P108
Q61894480-2E26461C-CBBE-4AF8-B864-31232CD83E5AQ61906846-2D372B3D-B344-44DC-8EA5-2EEE729FB694Q61906852-F2922257-2DC6-4F47-A346-CB0D09BD9868Q61918321-44B07689-AE25-4962-BFEA-85A79681F172Q61920584-EA4845A8-A2FE-415C-A236-BF3089D80268Q61921206-ECC471AD-0DAC-431D-9A61-6E919D231878Q61921211-DC4874D9-EC9D-4C93-A6F8-119D88DB2BE0Q61921378-E7945110-7A54-432A-850A-87E9E3D20D45Q61921821-181233DB-D2B9-4526-81CF-E5CAA16144B5Q61921855-25D85201-1A28-49CB-AD39-D115297222F0Q61921942-C89F2EB9-9734-41A5-8F84-E5B60916FE85Q61922269-569FE3D9-0A01-4E0A-8EE7-632F72A680E3Q61922290-8CEA28D4-7337-4243-82A9-20464B911875Q61932609-72534256-17B9-4AAF-8C7B-6DEC2776A13FQ61932635-8D7ABBE0-D9BC-4A44-93ED-3FE7D8E8886EQ61932690-6BB4D8A1-E92E-4B28-B9F7-7E0AB5A5E4C1Q61932747-DD9051E9-FC44-4CA8-BEFB-4EE358A2FD2EQ61932764-1BF328D7-24F7-476A-AB7B-840493506531Q61932787-B40D1061-06A8-4FAD-A39E-7814B0797CD4Q61933477-CD091FA8-9805-4067-B81F-47D9E5F16A1CQ61936128-C1EB0E22-2953-435B-801F-B7B852CBB418Q61936129-4185A45A-1304-4BD9-B5F2-9EBB51FA5641Q61939367-47215203-EC1C-46BC-99BE-A02F8780061CQ61956080-9201AD2B-5CBE-4343-8C04-C0CF579D055BQ61956085-DA52DB58-B5B8-4DD2-9AD4-8ADD96EB824FQ61967896-7274D839-B9BA-47D8-88D0-4607CCB7763BQ61969332-924BAA16-526E-4E75-8C7E-1799BFD91414Q61975132-5D6E9667-9018-48DA-8E1C-12665DCC2925Q61975576-0B75E4CC-5CFB-4F68-B5AF-05C9514078ACQ62025236-EF996B98-31DC-4F42-8964-046BBECCDE2FQ62031666-9DA761FC-7326-480A-91E7-5C8001764F44Q62035012-789467F0-C395-40E0-9E70-54898C70B2A3Q62041869-62B58ABD-DAD0-4312-B17D-2665D9A2E5BDQ62041916-03E33DD5-907B-4419-88F0-449B0AAA594CQ62055024-8C68D0F5-E9D4-4889-8D75-02D68C2EC798Q62105720-C9F44F45-B111-42CF-A03E-B599C5A3A184Q62110782-1842B102-4A59-4D36-9106-13B1DB54F12CQ62813040-E4C6EF9E-E84F-4481-9A61-0C003D00115AQ62813268-7E27E6C6-47FD-4506-ACFD-7A8CBEFE368AQ63012166-96E0CC19-500C-4158-BABA-E285F3829CAE
P859
name
Institut Psiquiàtric de l'Estat de Nova York
@ca
Instituto Psiquiátrico del Estado de Nueva York
@es
New York State Psychiatric Institute
@en
New York State Psychiatric Institute
@pl
ニューヨーク州精神医学研究所
@ja
紐約州精神病研究所
@zh-hant
纽约州精神病研究所
@zh
纽约州精神病研究所
@zh-cn
纽约州精神病研究所
@zh-hans
type
label
Institut Psiquiàtric de l'Estat de Nova York
@ca
Instituto Psiquiátrico del Estado de Nueva York
@es
New York State Psychiatric Institute
@en
New York State Psychiatric Institute
@pl
ニューヨーク州精神医学研究所
@ja
紐約州精神病研究所
@zh-hant
纽约州精神病研究所
@zh
纽约州精神病研究所
@zh-cn
纽约州精神病研究所
@zh-hans
altLabel
Instituto Psiquiatrico del Estado de Nueva York
@es
prefLabel
Institut Psiquiàtric de l'Estat de Nova York
@ca
Instituto Psiquiátrico del Estado de Nueva York
@es
New York State Psychiatric Institute
@en
New York State Psychiatric Institute
@pl
ニューヨーク州精神医学研究所
@ja
紐約州精神病研究所
@zh-hant
纽约州精神病研究所
@zh
纽约州精神病研究所
@zh-cn
纽约州精神病研究所
@zh-hans
P1566
P214
P244
P646
P131
P1566
P214
P244
P3417
New-York-State-Psychiatric-Institute
P3500
P373
New York State Psychiatric Institute
P625
Point (-73.9444 40.8425)
P646
P6773
P691
kn20050622006
P7859
lccn-n50077621